Yasushi Okura

Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model

Akitoshi Douhara, Kei Moriya, Hitoshi Yoshiji et al. · Molecular Medicine Reports · 2014 · 73 citations · Full text

Intestinal Permeability, Liver Fibrosis, Dysbiosis +29

von Willebrand factor is a useful biomarker for liver fibrosis and prediction of hepatocellular carcinoma development in patients with hepatitis B and C

Hiroaki Takaya, Hideto Kawaratani, Yuki Tsuji et al. · United European Gastroenterology Journal · 2018 · 48 citations · Full text

Ipragliflozin, a sodium–glucose cotransporter 2 inhibitor, ameliorates the development of liver fibrosis in diabetic Otsuka Long–Evans Tokushima fatty rats

Norihisa Nishimura, Mitsuteru Kitade, Ryuichi Noguchi et al. · Journal of Gastroenterology · 2016 · 43 citations

Inflammation, Metabolic Syndrome, Sodium–glucose Cotransporter 2 +11

Efficacy of alogliptin in preventing non-alcoholic fatty liver disease progression in patients with type 2 diabetes

Tsuyoshi Mashitani, Ryuichi Noguchi, Yasushi Okura et al. · Biomedical Reports · 2016 · 42 citations · Full text

Pathology, Fatty Liver Disease, Obesity +16

Combining probiotics and an angiotensin‐II type 1 receptor blocker has beneficial effects on hepatic fibrogenesis in a rat model of non‐alcoholic steatohepatitis

Yasuhiko Sawada, Hideto Kawaratani, Takuya Kubo et al. · Hepatology Research · 2018 · 34 citations